Login to Your Account

Pharma: Other News To Note

Monday, July 16, 2012

• Watson Pharmaceuticals Inc., of Parsippany, N.J., said the FDA approved its abbreviated new drug application for Next Choice One Dose (levonorgestrel tablet, 1.5 mg), the generic equivalent to Jerusalem-based Teva Pharmaceutical Industries Ltd.'s Plan B One-Step. Watson plans to launch immediately.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription